Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer [Phase 2]
Phase 2 trial assessing toripalimab with chemoradiotherapy for unresectable esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer [Phase 2]
Phase 2 trial update examining a biomarker-guided first-line immunotherapy combined with chemotherapy in advanced esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 trial evaluating short-course neoadjuvant chemo-radiotherapy plus toripalimab for locoregionally advanced resectable esophageal squa…
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer [Phase 3]
Phase 3 trial investigating trastuzumab and pertuzumab for HER2-positive resectable esophageal cancer (esophageal adenocarcinoma) is current…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Endoesophageal Brachytherapy for Patients With Esophageal Cancer [NA]
Clinical trial update for endoesophageal brachytherapy in esophageal cancer; study completed with results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: A Study of Durvalumab (MEDI4736) in Esophageal Cancer [Phase 2]
Phase 2 trial of durvalumab in esophageal cancer has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study [Phase 2]
A Phase 2 randomized trial comparing esophageal arterial infusion chemotherapy to systemic intravenous chemotherapy in resectable locally ad…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in HER2-positive gastroesophageal adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. [Phase 1, Phase 2]
A clinical trial update for an anti-PD-L1 antibody combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma (Phase 1/Pha…
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Pembrolizumab in Refractory Advanced Esophageal Cancer [Phase 2]
Phase 2 trial update on pembrolizumab for refractory advanced esophageal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer [Phase 2]
Phase 2 clinical trial updating nimotuzumab combined with radiotherapy for esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin [Phase 3]
A Phase 3 trial in esophageal cancer comparing nivolumab plus ipilimumab, or nivolumab with fluorouracil plus cisplatin, against fluorouraci…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer [Phase 2]
Phase 2 trial exploring camrelizumab with chemoradiotherapy for local recurrence of esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
Clinical trial investigating predictors of tumor response and radiation therapy side effects in gastrointestinal cancers; terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer [Phase 3]
A Phase 3 trial assessing nivolumab in unresectable advanced or recurrent esophageal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer [Phase 2]
Phase II multicenter randomized trial evaluating first-line chemotherapy with camrelizumab with or without radiotherapy for oligometastatic …
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC [Phase 2]
Phase 2 clinical trial investigating camrelizumab as consolidation therapy after radical concurrent chemoradiotherapy in locally advanced es…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy [Phase 2]
Phase 2 trial evaluating PET scan imaging to assess response in patients with esophageal cancer treated with combination chemotherapy; study…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell [Phase 3]
Phase 3 trial evaluating SHR-1210 (PD-1 antibody) plus apatinib versus SHR-1210 alone as second-line treatment for advanced esophageal squam…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer [Phase 3]
Phase 3 study evaluating camrelizumab in combination with concurrent chemoradiotherapy for locally advanced esophageal cancer is ongoing; no…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for Ave-CRT in newly diagnosed metastatic esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma. [Phase 2]
Phase 2 trial evaluating porcine fibrin sealant to prevent cervical anastomotic leakage after esophageal or gastroesophageal junction cancer…
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 trial evaluating nivolumab versus placebo in patients with resected esophageal or gastroesophageal junction cancer has completed a…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…